BSE filing, BSE: 543500. Summary written from the filing by ALFA Finder's alert engine.
Evoq Remedies Ltd: key numbers
- Share price
- ₹1.63
- Market cap
- ₹4.06 Cr
- Revenue (annual)
- ₹25.51 Cr
- Net profit (annual)
- ₹-0.24 Cr
- P/E (TTM)
- -16.9×Sector 52.3×
- Promoter holding
- 0.02%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Evoq Remedies Ltd
All →Evoq Remedies Insolvency Petition
NCLT admitted CIRP against Evoq Remedies Ltd for a Rs.1.95 Crore operational debt. An IRP has been appointed, and a moratorium is in effect.
- Value
- ₹1.95 Cr
Evoq Remedies Insolvency Petition
An operational creditor has filed an insolvency petition against Evoq Remedies under IBC Section 9. The NCLT admission initiates the CIRP process, posing significant risk for shareholders.
Evoq Remedies Financial Results
Evoq Remedies Limited reported audited financial results for the year ended March 31, 2026. The auditor issued a qualified opinion citing material uncertainty regarding going concern.
Evoq Remedies H2 FY26 Results: Net Loss of ₹0.3 Cr
Evoq Remedies Ltd reported a net loss of ₹0.3 Cr for H2 FY26.
- Key figure
- Net loss ₹0.3 Cr
Evoq Remedies Financial Results
Evoq Remedies Limited reported annual revenue of ₹26.76 Crore for FY2026. The board also appointed M/s. Jay Pandya & Associates as secretarial auditors for FY2025-26.
- Value
- ₹26.76 Cr
Evoq Remedies Board Meeting Date
Evoq Remedies rescheduled its board meeting from May 27 to May 30, 2026. Directors will consider audited financial results for the fiscal year ended March 31.
Other other announcement announcements
All →STL Networks Other Announcement
The Monitoring Agency reported Rs. 2 Crore utilization of Preferential Issue proceeds, with no deviations from objects. The report covers the quarter ending September 30, 2026.
HEG Advanced Materials Other Announcement
HEG Advanced Materials Limited has intimated the exchange regarding the change of its Corporate Identification Number (CIN) following an approved scheme of arrangement.
Sanofi India Other Announcement
Sanofi India issued a communication regarding Tax Deduction at Source (TDS) for the interim dividend declared for FY 2026. Shareholders must update details by November 5, 2026.
Visaka Industries Other Announcement
Visaka Industries informed the exchange about sending reminder letters to shareholders regarding the compulsory transfer of unclaimed dividends and equity shares to the IEPF account.
Arvaya Healthcare Other Announcement
Arvaya Healthcare filed its quarterly shareholding pattern under Regulation 31(1)(c). The filing reports routine ownership breakdowns with no transaction.
AYM Syntex Other Announcement
AYM Syntex's board appointed BSR & Co. LLP as statutory auditor for five years, subject to shareholder approval. Routine auditor appointment; no monetary value involved.
- Execution
- Five consecutive years, from the conclusion of the 44th AGM to the conclusion of the 49th AGM